MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $40.47 million. The enterprise value is $31.06 million.
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 42.02 million shares outstanding. The number of shares has increased by 88.67% in one year.
| Current Share Class | 42.02M |
| Shares Outstanding | 42.02M |
| Shares Change (YoY) | +88.67% |
| Shares Change (QoQ) | +2.74% |
| Owned by Insiders (%) | 10.60% |
| Owned by Institutions (%) | 4.64% |
| Float | 35.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.33 |
| P/TBV Ratio | 4.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 82.16
| Current Ratio | 82.16 |
| Quick Ratio | 81.97 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -184.32% and return on invested capital (ROIC) is -115.00%.
| Return on Equity (ROE) | -184.32% |
| Return on Assets (ROA) | -112.66% |
| Return on Invested Capital (ROIC) | -115.00% |
| Return on Capital Employed (ROCE) | -104.73% |
| Weighted Average Cost of Capital (WACC) | 12.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.46M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.59% in the last 52 weeks. The beta is 1.50, so MIRA's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -27.59% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 39.31 |
| Average Volume (20 Days) | 139,170 |
Short Selling Information
The latest short interest is 412,249, so 0.98% of the outstanding shares have been sold short.
| Short Interest | 412,249 |
| Short Previous Month | 378,494 |
| Short % of Shares Out | 0.98% |
| Short % of Float | 1.18% |
| Short Ratio (days to cover) | 2.56 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.79M |
| Pretax Income | -9.81M |
| Net Income | -31.37M |
| EBITDA | n/a |
| EBIT | -9.79M |
| Earnings Per Share (EPS) | -$1.04 |
Full Income Statement Balance Sheet
The company has $9.41 million in cash and n/a in debt, with a net cash position of $9.41 million or $0.22 per share.
| Cash & Cash Equivalents | 9.41M |
| Total Debt | n/a |
| Net Cash | 9.41M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | 9.35M |
| Book Value Per Share | 0.22 |
| Working Capital | 9.31M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -4.23M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 242,258 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |